Article Text

PDF

OHP-020 De-Escalation Strategy of Empirical Antibiotic Treatment with Carbapenems
  1. S Sadyrbaeva,
  2. P Aznarte Padial,
  3. N El-Fahimi,
  4. E Puerta García,
  5. S Caparrós Romero,
  6. A Madrid Paredes,
  7. MA Calleja Hernández
  1. Virgen de las Nieves University Hospital, Hospital Farmacy, Granada, Spain

Abstract

Background Therapeutic de-escalation enables us to improve the effectiveness of empirical antimicrobial therapy and avoids the development of resistance.

Purpose To analyse the preliminary results of a pilot project of pharmacy interventions to achieve de-escalation of treatment with carbapenems, within a programme of optimisation of antibiotics use.

Materials and Methods Prospective study of pharmacy interventions aimed at de-escalation in patients starting treatment with carbapenems, over three months (from March to June 2012) in a tertiary hospital, based on available microbiology results. The de-escalation suggestion was made through the electronic prescribing software. The variables analysed were: number of patients prescribed carbapenems, prescribing speciality, request for cultures, microorganisms isolated and interventions performed. De-escalations carried out without pharmacy intervention were also assessed.

Results Total number of prescriptions was 433. The most prescribed carbapenem was ertapenem (37.6%) followed by meropenem (36%). The carbapenem most used in Internal Medicine was meropenem (58.2%) and in Urology, imipenem (75%). Ertapenem was used more frequently in General Surgery (53.7%) and Vascular Surgery (86.0%). Out of a total of 316 requested tests, 172 (54.4%) were positive. The most common pathogen isolated was Escherichia Coli (24.7%) 20.8% of which were Extended-Spectrum Beta-Lactamase (ESBL)-producing, 60% of which were sensitive to piperacillin-tazobactam or fosfomycin. Klebsiella spp. were isolated in 3.6%, of which 33.3% were ESBL-producing and 50% were sensitive to piperacillin-tazobactam. Total treatments subject to de-escalation were 96 (55.8%), out of 172 showing this possibility, where 74 (77.1%) were carried out by initiatives of medical teams and 22 (22.9%) after pharmacy interventions. The Services with a higher degree of acceptance of pharmacy interventions were Internal Medicine (36.4%) and General Surgery (27.3%).

Conclusions Although the therapeutic de-escalation of empirical treatments with carbapenems was a low percentage, nevertheless pharmacy interventions achieved an increase of this practise, with the more receptive specialties being Internal Medicine and General Surgery.

No conflict of interest.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.